Myriad Genetics Inc (MYGN):企業の財務・戦略的SWOT分析

【英語タイトル】Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C5265)・商品コード:DATA904C5265
・発行会社(調査会社):GlobalData
・発行日:2018年9月
・ページ数:58
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Myriad Genetics Inc (MYGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient’s likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

Myriad Genetics Inc Key Recent Developments

Aug 21,2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results
May 28,2018: Myriad Genetics Signs Definitive Agreement to Acquire Counsyl
May 08,2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results
May 04,2018: Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer
Apr 23,2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against  Myriad Genetics, Inc.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Myriad Genetics Inc – Key Facts 6
Myriad Genetics Inc – Key Employees 7
Myriad Genetics Inc – Key Employee Biographies 8
Myriad Genetics Inc – Major Products and Services 9
Myriad Genetics Inc – History 11
Myriad Genetics Inc – Company Statement 18
Myriad Genetics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 21
Company Overview 21
Myriad Genetics Inc – Business Description 22
Business Segment: Diagnostics Segment 22
Overview 22
Performance 22
Business Segment: Other Segment 22
Overview 22
Performance 22
R&D Overview 22
Myriad Genetics Inc – Corporate Strategy 23
Myriad Genetics Inc – SWOT Analysis 24
SWOT Analysis – Overview 24
Myriad Genetics Inc – Strengths 24
Myriad Genetics Inc – Weaknesses 25
Myriad Genetics Inc – Opportunities 26
Myriad Genetics Inc – Threats 27
Myriad Genetics Inc – Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios – Capital Market Ratios 29
Financial Ratios – Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios – Interim Ratios 34
Financial Ratios – Ratio Charts 35
Section 4 – Company’s Lifesciences Financial Deals and Alliances 36
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 36
Myriad Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 37
Myriad Genetics Inc, Recent Deals Summary 38
Section 5 – Company’s Recent Developments 39
Aug 21, 2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results 39
May 08, 2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results 42
May 07, 2018: Genome Medical Enters Employer Market with Diverse Genetic Health Programs and Wave of New Partners 44
Apr 23, 2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against  Myriad Genetics, Inc. 45
Apr 18, 2018: Counsyl to offer insight into streamlining genetic screening into OBGYN practice at the 2018 ACOG Annual Clinical and Scientific Meeting 46
Apr 04, 2018: Counsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics Meeting 47
Feb 06, 2018: Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results 49
Jan 04, 2018: Counsyl Appoints Ann Rhoads to Board of Directors 51
Dec 14, 2017: Counsyl Appoints Pamela Sedmak to Board of Directors 52
Dec 04, 2017: Counsyl Appoints Noah Nasser as Chief Commercial Officer 53
Section 6 – Appendix 54
Methodology 54
Ratio Definitions 54
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Myriad Genetics Inc, Key Facts 6
Myriad Genetics Inc, Key Employees 7
Myriad Genetics Inc, Key Employee Biographies 8
Myriad Genetics Inc, Major Products and Services 9
Myriad Genetics Inc, History 11
Myriad Genetics Inc, Subsidiaries 19
Myriad Genetics Inc, Key Competitors 28
Myriad Genetics Inc, Ratios based on current share price 29
Myriad Genetics Inc, Annual Ratios 30
Myriad Genetics Inc, Annual Ratios (Cont...1) 31
Myriad Genetics Inc, Annual Ratios (Cont...2) 32
Myriad Genetics Inc, Interim Ratios 34
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 36
Myriad Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 37
Myriad Genetics Inc, Recent Deals Summary 38
Currency Codes 54
Capital Market Ratios 54
Equity Ratios 55
Profitability Ratios 55
Cost Ratios 56
Liquidity Ratios 56
Leverage Ratios 57
Efficiency Ratios 57

List of Figures
Myriad Genetics Inc, Performance Chart (2014 - 2018) 33
Myriad Genetics Inc, Ratio Charts 35
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 36
Myriad Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 37

★調査レポート[Myriad Genetics Inc (MYGN):企業の財務・戦略的SWOT分析] (コード:DATA904C5265)販売に関する免責事項を必ずご確認ください。
★調査レポート[Myriad Genetics Inc (MYGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆